• Revenue up 22% to $3.9M
• EBITDA up 41% to $1.0M
• NPAT up 59% to $0.6M
• Expansion into new freehold warehouse facility

Cryosite Ltd (ASX: CTE) has reported a strong financial and operational performance for the first quarter of the 2026 financial year (Q1 FY26). Revenue increased by 22% to $3.9 million, EBITDA grew by 41% to $1.0 million, and NPAT rose by 59% to $0.6 million compared to the same period in the previous year. The company's growth was driven by increasing demand across its key revenue segments, including Ambient, Cold, and Frozen, as well as Ultra-Frozen and Cryogenic. Cryosite has maintained strong relationships with its major clients, who are expanding their partnerships with the company, and the business development team has onboarded several new clients. The company is also progressing with the acquisition of a freehold warehouse facility in Adderley St, Auburn, NSW, which will add over 100% capacity to Cryosite's operations and enhance its service offerings, scalability, and dual-site security for clients. Cryosite's Cord Blood business is also delivering increasing cash revenues as legacy contracts expire, with strong client commitment to continue storage services. The company enters Q2 FY26 with positive momentum, a growing client base, and a clear focus on expanding its operations into the new Adderley St warehouse and scaling its Ultra-Frozen and Cryogenic segment.

Cryosite expects continued strong demand for its compliant, high-integrity storage and logistics services, which the company is uniquely placed to meet. The company has not provided any specific financial guidance for the current financial year.

Cryosite enters Q2 FY26 with positive momentum, a growing client base, and a clear focus on expanding its operations into the new Adderley St warehouse and scaling its Ultra-Frozen and Cryogenic segment. Demand for compliant, high-integrity storage and logistics continues to rise, and Cryosite is well-positioned to meet this demand.